Neuroimaging Correlates with Clinical Severity in Wilson Disease: A Multiparametric Quantitative Brain MRI

References

1. 1.↵
   1. Członkowska A,
   2. Litwin T,
   3. Dusek P, et al

   . Wilson disease. Nat Rev Dis Primers 2018;4:21 doi:10.1038/s41572-018-0018-3 pmid:30190489

   CrossRefPubMed
2. 2.↵
   1. Litwin T,
   2. Gromadzka G,
   3. Szpak GM, et al

   . Brain metal accumulation in Wilson’s disease. J Neurol Sci 2013;329:55–58 doi:10.1016/j.jns.2013.03.021 pmid:23597670

   CrossRefPubMed
3. 3.↵
   1. Mikol J,
   2. Vital C,
   3. Wassef M, et al

   . Extensive cortico-subcortical lesions in Wilson’s disease: clinico-pathological study of two cases. Acta Neuropathol 2005;110:451–58 doi:10.1007/s00401-005-1061-1 pmid:16195917

   CrossRefPubMed
4. 4.↵
   1. Meenakshi-Sundaram S,
   2. Mahadevan A,
   3. Taly AB, et al

   . Wilson’s disease: a clinico-neuropathological autopsy study. J Clin Neurosci 2008;15:409–17 doi:10.1016/j.jocn.2006.07.017 pmid:18242093

   CrossRefPubMed
5. 5.↵
   1. Dusek P,
   2. Bahn E,
   3. Litwin T, et al

   . Brain iron accumulation in Wilson disease: a post mortem 7 Tesla MRI - histopathological study. Neuropathol Appl Neurobiol 2017;43:514–32 doi:10.1111/nan.12341 pmid:27543917

   CrossRefPubMed
6. 6.↵
   1. Fritzsch D,
   2. Reiss-Zimmermann M,
   3. Trampel R, et al

   . Seven-Tesla magnetic resonance imaging in Wilson disease using quantitative susceptibility mapping for measurement of copper accumulation. Invest Radiology 2014;49:299–306 doi:10.1097/RLI.0000000000000010 pmid:24220252

   CrossRefPubMed
7. 7.↵
   1. Jadav R,
   2. Saini J,
   3. Sinha S, et al

   . Diffusion tensor imaging (DTI) and its clinical correlates in drug naïve Wilson’s disease. Metab Brain Dis 2013;28:455–62 doi:10.1007/s11011-013-9407-1 pmid:23636656

   CrossRefPubMed
8. 8.↵
   1. Rose J,
   2. Vassar R,
   3. Cahill-Rowley K, et al

   . Brain microstructural development at near-term age in very-low-birth-weight preterm infants: an atlas-based diffusion imaging study. Neuroimage 2014;86:244–56 doi:10.1016/j.neuroimage.2013.09.053 pmid:24091089

   CrossRefPubMed
9. 9.↵
   1. Wang A,
   2. Wu H,
   3. Xu C, et al

   . Study on lesion assessment of cerebello-thalamo-cortical network in Wilson’s disease with diffusion tensor imaging. Neural Plast 2017;2017:7323121 doi:10.1155/2017/7323121 pmid:28781902

   CrossRefPubMed
10. 10.↵
    1. Dong T,
    2. Yang WM,
    3. Wu MC, et al

    . Microstructure changes in white matter relate to cognitive impairment in Wilson’s disease. Biosci Rep 2019;39:BSR20181651

    Abstract/FREE Full Text
11. 11.↵
    1. Karimi A,
    2. Mohammadi S,
    3. Salehi MA, et al

    . Brain microstructural abnormalities in patients with Wilson’s disease: a systematic review of diffusion tenor imaging studies. Brain Imaging Behav 2022;16:2809–40 doi:10.1007/s11682-022-00733-7 pmid:36327021

    CrossRefPubMed
12. 12.↵
    1. Lehéricy S,
    2. Roze E,
    3. Goizet C, et al

    . MRI of neurodegeneration with brain iron accumulation. Curr Opin Neurol 2020;33:462–73 doi:10.1097/WCO.0000000000000844 pmid:32657887

    CrossRefPubMed
13. 13.↵
    1. Doganay S,
    2. Gumus K,
    3. Koc G, et al

    . Magnetic susceptibility changes in the basal ganglia and brainstem of patients with Wilson’s disease: evaluation with quantitative susceptibility mapping. Magn Reson Med Sci 2018;17:73–79 doi:10.2463/mrms.mp.2016-0145 pmid:28515413

    CrossRefPubMed
14. 14.↵
    1. Dezortova M,
    2. Lescinskij A,
    3. Dusek P, et al

    . Multiparametric quantitative brain MRI in neurological and hepatic forms of Wilson’s disease. J Magn Reson Imaging 2020;51:1829–35 doi:10.1002/jmri.26984 pmid:31710776

    CrossRefPubMed
15. 15.↵
    1. Li G,
    2. Wu R,
    3. Tong R, et al

    . Quantitative measurement of metal accumulation in brain of patients with Wilson’s disease. Mov Disord 2020;35:1787–95 doi:10.1002/mds.28141 pmid:32681698

    CrossRefPubMed
16. 16.↵
    1. Shribman S,
    2. Bocchetta M,
    3. Sudre CH, et al

    . Neuroimaging correlates of brain injury in Wilson’s disease: a multimodal, whole-brain MRI study. Brain 2022;145:263–75 doi:10.1093/brain/awab274 pmid:34289020

    CrossRefPubMed
17. 17.↵
    1. Favrole P,
    2. Chabriat H,
    3. Guichard JP, et al

    . Clinical correlates of cerebral water diffusion in Wilson disease. Neurology 2006;66:384–89 doi:10.1212/01.wnl.0000196482.71636.7d pmid:16476937

    CrossRefPubMed
18. 18.↵
    1. Ferenci P,
    2. Caca K,
    3. Loudianos G, et al

    . Diagnosis and phenotypic classification of Wilson disease. Liver Int 2003;23:139–42 doi:10.1034/j.1600-0676.2003.00824.x pmid:12955875

    CrossRefPubMedWeb of Science
19. 19.↵
    European Association for Study of Liver. EASL Clinical Practice Guidelines: Wilson’s disease. J Hepatol 2012;56:671–85

    CrossRefPubMedWeb of Science
20. 20.↵
    1. Członkowska A,
    2. Tarnacka B,
    3. Möller JC, et al

    . Unified Wilson’s Disease Rating Scale—a proposal for the neurological scoring of Wilson’s disease patients. Neurol Neurochir Pol 2007;41:1–12

    PubMed
21. 21.↵
    1. Liu J,
    2. Liu T,
    3. de Rochefort L, et al

    . Morphology enabled dipole inversion for quantitative susceptibility mapping using structural consistency between the magnitude image and the susceptibility map. Neuroimage 2012;59:2560–68 doi:10.1016/j.neuroimage.2011.08.082 pmid:21925276

    CrossRefPubMed
22. 22.↵
    1. Jenkinson M,
    2. Beckmann CF,
    3. Behrens TE, et al

    . FSL. Neuroimage 2012;62:782–90 doi:10.1016/j.neuroimage.2011.09.015 pmid:21979382

    CrossRefPubMedWeb of Science
23. 23.↵
    1. Garyfallidis E,
    2. Brett M,
    3. Amirbekian B

    ; Dipy Contributors, et al. Dipy, a library for the analysis of diffusion MRI data. Front Neuroinform 2014;8:8 doi:10.3389/fninf.2014.00008 pmid:24600385

    CrossRefPubMed
24. 24.↵
    1. Budde MD,
    2. Janes L,
    3. Gold E, et al

    . The contribution of gliosis to diffusion tensor anisotropy and tractography following traumatic brain injury: validation in the rat using Fourier analysis of stained tissue sections. Brain 2011;134:2248–60 doi:10.1093/brain/awr161 pmid:21764818

    CrossRefPubMedWeb of Science
25. 25.↵
    1. Acosta-Cabronero J,
    2. Williams GB,
    3. Pengas G, et al

    . Absolute diffusivities define the landscape of white matter degeneration in Alzheimer’s disease. Brain 2010;133:529–39 doi:10.1093/brain/awp257 pmid:19914928

    CrossRefPubMedWeb of Science
26. 26.↵
    1. Concha L,
    2. Gross DW,
    3. Wheatley BM, et al

    . Diffusion tensor imaging of time-dependent axonal and myelin degradation after corpus callosotomy in epilepsy patients. Neuroimage 2006;32:1090–99 doi:10.1016/j.neuroimage.2006.04.187 pmid:16765064

    CrossRefPubMedWeb of Science
27. 27.↵
    1. Langkammer C,
    2. Krebs N,
    3. Goessler W, et al

    . Quantitative MR imaging of brain iron: a postmortem validation study. Radiology 2010;257:455–62 doi:10.1148/radiol.10100495 pmid:20843991

    CrossRefPubMedWeb of Science
28. 28.↵
    1. Dusek P,
    2. Lescinskij A,
    3. Ruzicka F, et al

    . Associations of brain atrophy and cerebral iron accumulation at MRI with clinical severity in Wilson disease. Radiology 2021;299:662–72 doi:10.1148/radiol.2021202846 pmid:33754827

    CrossRefPubMed
29. 29.↵
    1. Li G,
    2. Zhou X,
    3. Xu P, et al

    . Microstructure assessment of the thalamus in Wilson’s disease using diffusion tensor imaging. Clin Radiology 2014;69:294–98 doi:10.1016/j.crad.2013.10.016 pmid:24332168

    CrossRefPubMed